EURORDIS and more than 700 member organisations have just produced a new new position paper calling for urgent change to ensure rapid and full access to rare disease therapies for patients in Europe.
EURORDIS and more than 700 member organisations have just produced a new new position paper calling for urgent change to ensure rapid and full access to rare disease therapies for patients in Europe.